4
Changes in Ownership
AbCellera Biologics Inc. Filed Acc 0001209191-22-059568
Options or other derivatives
- Chief Financial Officer acquired 485,661 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Booth Andrew Chief Financial Officer | 2022-12-01 | Grant or award · Share Options (right to buy) | +485,661 | 5,870,481 | D | ||
Loading xslF345X03/doc4.xml…